Search

Search Results

• The efficacy of apremilast in pemphigus: a systematic review of case reports

  Roudin H. Alhasawi, Esraa A. Shaheen, Noura M. Alshabanat, Reem Brashi, Walaa Abdu Ahmed, Shumukh H. Alqahtani, Ethar G. Alharbi, Mazin Aljabri

  07-05-2025

  https://doi.org/10.4081/dr.2025.10245

  897

  PDF: 400

  SUPPLEMENTARY MATERIAL: 34

  HTML: 8
• 

  Erythrodermic psoriasis treated with apremilast

  John Arcilla, Daniel Joe, Johnathan Kim, Yohanan Kim, VuAnh N. Truong, Navin Jaipaul

  19-09-2016

  https://doi.org/10.4081/dr.2016.6599

  2122

  PDF: 964

  HTML: 600
• 

  Mycobacterium kansasii infection in a psoriasis patient treated with adalimumab and switch to apremilast: First report and literature review

  Alexandra Maria Giovanna Brunasso, Sanja Javor, Emanuele Pontali, Simona Sola, Cesare Massone

  29-07-2021

  https://doi.org/10.4081/dr.2021.8797

  3060

  PDF: 647

  HTML: 10
• 

  Atopic dermatitis: a brief review of recent advances in its management

  Sultan Daghafak Alenazi

  23-05-2023

  https://doi.org/10.4081/dr.2023.9678

  2393

  PDF: 1409

  HTML: 106
• 

  Psoriasis, biological drugs and Coronavirus Disease 2019: Real life experience of two Italian provinces

  Martina Vispi, Teresa Corradin, Camilla Peccianti, Luca Feci, Laura Casini, Chiara Pisani, Susanna Fabbroni, Paola Corsetti, Margherita Croatto, Michele Pellegrino

  25-06-2020

  https://doi.org/10.4081/dr.2020.8642

  1352

  PDF: 751

  HTML: 8
• 

  Certolizumab to treat hidradenitis suppurativa

  Asem Shadid, Saud Alobaida, Yousef Binamer

  27-10-2022

  https://doi.org/10.4081/dr.2022.9566

  1939

  PDF: 728

  HTML: 28
• 

  Maculopapular sarcoidosis: the importance of skin signs

  Giovanna Galdo, Gelsomina Luongo, Daniela Capacchione, Damiano Abeni, Marta Grimaldi, Luca Fania

  16-09-2022

  https://doi.org/10.4081/dr.2022.9561

  1009

  PDF: 378

  HTML: 25

• Efficacy of tildrakizumab 200 mg for treating difficult-to-treat patient populations with moderate-to-severe plaque psoriasis

  Paolo Dapavo, Matteo Megna, Marina Talamonti

  09-08-2024

  https://doi.org/10.4081/dr.2024.9999

  1739

  PDF: 669

  HTML: 94
• 

  Measuring the impact of pruritus in patients with epidermolysis bullosa: evaluation with an itch-specific instrument

  Ashjan Alheggi, Raneem Alnutaifi, Manal Alkhonezan, Norah Almudawi, Renad Alsuhaibani, Philip Moons, Turki Aljuhani

  18-05-2023

  https://doi.org/10.4081/dr.2023.9700

  1167

  PDF: 368

  APPENDIX S1: 180

  HTML: 8

• Efficacy of a topical polyphenol-based formulation in palmoplantar psoriasis: an observational study

  Simone Amato, Annunziata Dattola, Luigi Bennardo, Martina Tolone, Steven Paul Nisticò

  08-07-2025

  https://doi.org/10.4081/dr.2025.10333

  385

  PDF: 240

  HTML: 0

• S-MAPA: bridging the gap in psoriasis severity assessment

  Trang Thi Thuy Vu, Chuyen Thi Hong Nguyen, Trung The Van

  28-05-2025

  https://doi.org/10.4081/dr.2025.10231

  621

  PDF: 282

  HTML: 15
• 

  Seven cancer patients receiving guselkumab for treatment of moderate-to-severe psoriasis

  Luca Mastorino, Niccolò Siliquini, Gianluca Avallone, Michela Ortoncelli, Pietro Quaglino, Paolo Dapavo, Simone Ribero

  17-03-2022

  https://doi.org/10.4081/dr.2022.9282

  1162

  PDF: 825

  HTML: 41
• 

  Dimethyl fumarate as a safe and effective therapy for recalcitrant psoriasis in comorbid patients

  Martina Burlando, Mattia Fabio Molle, Emanuele Cozzani, Aurora Parodi

  14-03-2022

  https://doi.org/10.4081/dr.2022.9091

  2625

  PDF: 632

  HTML: 6